Mercury Bio Promotes Casey Perkins to Chief Business Officer
SANTA FE, N.M., June 23, 2026 /PRNewswire/ -- Mercury Bio, an intracellular immunotherapeutic biotechnology company focused on treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced the promotion of Cassandra "Casey" Perkins to Chief Business...
SANTA FE, N.M., June 23, 2026 /PRNewswire/ -- Mercury Bio, an intracellular immunotherapeutic biotechnology company focused on treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced the promotion of Cassandra "Casey" Perkins to Chief Business...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.